Candel Therapeutics (CADL) Earnings Date & Reports

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CADL is expected to report earnings to rise 73.71% to -24 cents per share on August 19

Candel Therapeutics CADL Stock Earnings Reports

Q2'26

Est.

$-0.24

Q1'26

Beat

by $0.20

Q4'25

Missed

by $0.29

Q3'25

Missed

by $0.03

Q2'25

Beat

by $0.07

The last earnings report on May 14 showed earnings per share of -14 cents, beating the estimate of -34 cents. With 1.05M shares outstanding, the current market capitalization sits at 617.67M.

View a ticker or compare two or three

Compare

CADL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CADL